Management ChangeJul 14, 2026, 09:01 PM
Tenaya Therapeutics Appoints Eric Hyllengren as CFO, Grants Stock Options
AI Summary
Tenaya Therapeutics Inc. announced the appointment of Eric Hyllengren as its new Chief Financial Officer. In connection with his employment, Mr. Hyllengren was granted stock options to purchase 1,650,000 shares of Tenaya common stock. Additionally, two new non-executive employees received options for an aggregate of 187,200 shares. These inducement grants have an exercise price of $0.8365 per share and vest over a four-year period.
Key Highlights
- Eric Hyllengren appointed as the new Chief Financial Officer.
- Granted stock options to CFO for 1,650,000 shares of common stock.
- Granted stock options to two new non-executive employees for 187,200 shares.
- Stock options have an exercise price of $0.8365 per share.
- Options vest over four years: 1/4th after one year, then 1/48th monthly.
- Grants made as inducement material under NASDAQ Listing Rule 5635(c)(4).
Price Impact
More from TNYA